Advancing Palliative Care for Older Adults Affected by Neurodegenerative Disease: Parkinsons disease, Alzheimers disease and Related Dementias
推进对受神经退行性疾病影响的老年人的姑息治疗:帕金森病、阿尔茨海默病和相关痴呆症
基本信息
- 批准号:10055394
- 负责人:
- 金额:$ 14.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-15 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdministrative SupplementAdultAdvance Care PlanningAdvanced DevelopmentAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease patientAlzheimer&aposs disease related dementiaAreaAwardCaregiver supportCaregiversCaringCause of DeathChronicCommunitiesDataDevelopmentDistressEducationEffectivenessElderlyFamilyFosteringFoundationsFundingFutureGoalsGrantHealth Care CostsHealth PolicyHome visitationIndividualInterventionInterviewLeadLeadershipLewy Body DementiaLifeMalignant NeoplasmsMedicalMental DepressionMentorsModelingNeurodegenerative DisordersNeurologic SymptomsNeurologistNeurologyNursing HomesOutcomeOutpatientsPainPain managementPalliative CareParkinson DiseasePatient-Focused OutcomesPatientsPersonalityPhysiciansPlayPopulationProgram Research Project GrantsPsychosocial InfluencesQuality of lifeRandomized Clinical TrialsResearchResearch PersonnelResourcesRoleServicesSiteSpecialistSymptomsTeleconferencesTestingTimeTrainingTransportationTransportation of PatientsUniversitiesWorkaging in placebaseburnoutcare systemscareercareer developmentcommunity settingcomparative effectiveness trialdesigneffectiveness testingefficacy trialend of life careexperiencehealth care disparityhealth care service utilizationhuman old age (65+)implementation scienceimprovedimproved outcomeinterestmedical specialtiesmeetingsnovelnovel strategiesonline communitypalliativepatient mobilityphysical symptompreferenceprogramspsychiatric symptompsychosocialrandomized trialsatisfactionstemtelehealthvirtual
项目摘要
Project Summary/Abstract: Neurodegenerative illnesses such as Parkinson’s (PD), Lewy Body Dementia
(LBD) and Alzheimer’s disease (AD) affect nearly 15% of adults over age 65 and are leading causes of death
in the US. While these illnesses are traditionally defined by their neurologic symptoms, more recent research
describes the high impact of other medical symptoms on patients and the immense psychosocial
consequences of these illnesses on both patients and families. Unfortunately, multiple lines of evidence
demonstrate that many of the needs most important to patients and caregivers (e.g. pain management,
advance care planning, end-of-life care) are poorly addressed under current care models. Palliative care is an
approach to caring for individuals with life-limiting illness that addresses potential causes of suffering including
physical symptoms, psychosocial issues and spiritual needs. To date there have been limited attempts to apply
these principles to neurodegenerative illnesses despite evidence that patients’ and caregivers’ unmet needs
may be amenable to this approach. Notably, the candidate has played a central role among a growing cadre of
academic centers that now offer palliative care services for neurodegenerative illnesses and presents results
from a randomized trial of academic-based outpatient palliative care that convincingly demonstrate this
approach improves patient and caregiver outcomes over current standards of care. While efficacy trials are
critical to forwarding this field, barriers to their dissemination include a limited workforce of palliative care
specialists, lack of palliative education amongst neurologists, lack of team-based resources in community
settings, and patient mobility/transportation issues. The long-term goal of the candidate is to improve outcomes
and raise standards of care for older adults affected by neurodegenerative illnesses through novel, efficient
and effective models of delivering palliative care. The Research Aims of this award will be met through: Study
1: Determine the effectiveness and feasibility of individual palliative care training for community neurologists
and team-based virtual house calls for PD/LBD patients and caregivers (funded R01); Study 2: Develop a
community-based model of palliative care for AD patients and caregivers (funded NIA AD Administrative
Supplement; R01 trial to stem from results); Study 3: Determine the effectiveness and feasibility of a novel
online community model to support community-based palliative care for PD/LBD (R01 Under Review); and
Study 4: Integrate geriatric principles and care into our neuropalliative care model to improve outcomes for
patients and caregivers affected by neurodegenerative illness (future P01 grant). As this is an emerging
research direction for the candidate, the Career Development Objectives will provide formal training in
academic leadership, geriatric palliative care, implementation science, caregiver support, telehealth and
healthcare policy. This proposal is significant because it will create a foundation for palliative care
dissemination efforts relevant to neurodegenerative illness and the broader field of geriatric palliative care.
项目摘要/摘要:神经退行性疾病,如帕金森病 (PD)、路易体痴呆
(LBD) 和阿尔茨海默病 (AD) 影响近 15% 的 65 岁以上成年人,是导致死亡的主要原因
在美国,虽然这些疾病传统上是根据神经系统症状来定义的,但最近的研究表明。
描述了其他医学症状对患者的严重影响以及巨大的心理社会影响
不幸的是,这些疾病对患者和家庭的后果有多种证据。
证明许多对患者和护理人员来说最重要的需求(例如疼痛管理、
临终关怀)在当前的护理模式下没有得到很好的解决。
照顾患有生命有限疾病的个人的方法,解决造成痛苦的潜在原因,包括
迄今为止,针对身体症状、心理社会问题和精神需求的尝试有限。
尽管有证据表明患者和护理人员的需求未得到满足,但神经退行性疾病的这些原则
值得注意的是,候选人在不断壮大的骨干队伍中发挥了核心作用。
现在为神经退行性疾病提供姑息治疗服务并展示结果的学术中心
来自一项基于学术的门诊姑息治疗的随机试验令人信服地证明了这一点
与当前的护理标准相比,该方法改善了患者和护理人员的结果。
对于推进这一领域至关重要,其传播的障碍包括姑息治疗人员有限
专家、神经科医生缺乏姑息教育、社区缺乏基于团队的资源
候选人的长期目标是改善结果。
通过新颖、有效的方法提高受神经退行性疾病影响的老年人的护理标准
提供姑息治疗的有效模式 该奖项的研究目标将通过以下方式实现: 研究。
1:确定社区神经科医生个体姑息治疗培训的有效性和可行性
以及针对 PD/LBD 患者和护理人员的基于团队的虚拟上门服务(资助 R01);
针对 AD 患者和护理人员的基于社区的姑息治疗模式(由 NIA AD 行政部门资助)
补充;R01试验源于研究3:确定新颖性的有效性和可行性
支持基于社区的 PD/LBD 姑息治疗的在线社区模式(R01 正在审查中);
研究 4:将老年病学原则和护理融入我们的神经姑息护理模型中,以改善患者的治疗结果
受神经退行性疾病影响的患者和护理人员(未来 P01 补助金),因为这是一项新兴疾病。
候选人的研究方向,职业发展目标将提供正式培训
学术领导、老年姑息治疗、实施科学、护理人员支持、远程医疗和
该提案意义重大,因为它将为姑息治疗奠定基础。
与神经退行性疾病和更广泛的老年姑息治疗领域相关的传播工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BENZI M KLUGER其他文献
BENZI M KLUGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BENZI M KLUGER', 18)}}的其他基金
Developing a Prediction Model to Improve End‐of‐Life Prognostication and Hospice Referral in Parkinson's Disease
开发预测模型以改善帕金森病的临终预测和临终关怀转诊
- 批准号:
10524354 - 财政年份:2022
- 资助金额:
$ 14.22万 - 项目类别:
Advancing Palliative Care for Older Adults Affected by Neurodegenerative Disease: Parkinsons disease, Alzheimers disease and Related Dementias
推进对受神经退行性疾病影响的老年人的姑息治疗:帕金森病、阿尔茨海默病和相关痴呆症
- 批准号:
10264138 - 财政年份:2020
- 资助金额:
$ 14.22万 - 项目类别:
Advancing Palliative Care for Older Adults Affected by Neurodegenerative Disease: Parkinsons disease, Alzheimers disease and Related Dementias
推进对受神经退行性疾病影响的老年人的姑息治疗:帕金森病、阿尔茨海默病和相关痴呆症
- 批准号:
10468798 - 财政年份:2020
- 资助金额:
$ 14.22万 - 项目类别:
More than a Movement Disorder: Applying Palliative Care to Parkinson's Disease
不仅仅是运动障碍:对帕金森病进行姑息治疗
- 批准号:
9175308 - 财政年份:2016
- 资助金额:
$ 14.22万 - 项目类别:
More than a Movement Disorder: Applying Palliative Care to Parkinson's Disease and Lewy Body Dementias
不仅仅是运动障碍:对帕金森病和路易体痴呆症进行姑息治疗
- 批准号:
10298020 - 财政年份:2016
- 资助金额:
$ 14.22万 - 项目类别:
More than a Movement Disorder: Applying Palliative Care to Parkinson's Disease and Lewy Body Dementias
不仅仅是运动障碍:对帕金森病和路易体痴呆症进行姑息治疗
- 批准号:
10298020 - 财政年份:2016
- 资助金额:
$ 14.22万 - 项目类别:
Finding the Ethical Path Forward: A Bioethical and Stakeholder-driven Investigation on the Sharing of Palliative-related Survey Results with Patients, Caregivers and Community Clinicians
寻找前进的道德道路:关于与患者、护理人员和社区临床医生共享姑息治疗相关调查结果的生物伦理和利益相关者驱动的调查
- 批准号:
10790789 - 财政年份:2016
- 资助金额:
$ 14.22万 - 项目类别:
More than a Movement Disorder: Applying Palliative Care to Parkinson's Disease and Lewy Body Dementias
不仅仅是运动障碍:对帕金森病和路易体痴呆症进行姑息治疗
- 批准号:
10657697 - 财政年份:2016
- 资助金额:
$ 14.22万 - 项目类别:
Characterizing Intrinsic Functional Cortical Networks in Parkinson Disease Dementia
帕金森病痴呆的内在功能皮质网络特征
- 批准号:
9111686 - 财政年份:2016
- 资助金额:
$ 14.22万 - 项目类别:
Intrinsic Cortical Networks and Cognitive Dysfunction in Parkinson???s Disease
帕金森病的内在皮质网络和认知功能障碍
- 批准号:
8635587 - 财政年份:2013
- 资助金额:
$ 14.22万 - 项目类别:
相似海外基金
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)Scientific Leadership Center; ADMIN SUPPLEMENT
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心;
- 批准号:
10855435 - 财政年份:2023
- 资助金额:
$ 14.22万 - 项目类别:
Developing a culturally adapted implementation program for teleophthalmology use in Latinx communities
制定适合拉丁裔社区远程眼科使用的文化适应实施计划
- 批准号:
10771837 - 财政年份:2023
- 资助金额:
$ 14.22万 - 项目类别:
Assessing the real-world impact of a low nicotine product standard for smoked tobacco in New Zealand
评估新西兰低尼古丁产品标准对吸食烟草的现实影响
- 批准号:
10665851 - 财政年份:2023
- 资助金额:
$ 14.22万 - 项目类别:
Optimizing Environmental Enrichment to Model Preclinical Neurorehabilitation
优化环境富集以模拟临床前神经康复
- 批准号:
10789355 - 财政年份:2023
- 资助金额:
$ 14.22万 - 项目类别:
Funded extension request for "Expanding recovery support for emerging adults with alcohol use disorder: Training in the science of social network sites"
为“扩大对患有酒精使用障碍的新兴成年人的康复支持:社交网站科学培训”的延期请求提供资助
- 批准号:
10717217 - 财政年份:2023
- 资助金额:
$ 14.22万 - 项目类别: